Benny Johnson

The University of Texas MD Anderson Cancer Center

Also affiliated with Agenus (United States), Institute for High Technologies and Systems

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

(2023)10.1158/2767-9764.c.6975005.v1

Top 100%

0DataRank

Top 100%0 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Papers

Driven by 20 papers — median percentile 0. Top paper: “The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients”.

The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients

British Journal of Cancer(2020)10.1038/s41416-020-01169-w

N/A

0.483DataRank · unranked

24 citations

Timothy J. Vreeland, Benny Johnson, Yoshikuni Kawaguchi, Steven H. Wei, Y. Nancy You +4 more

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution

The Oncologist(2022)10.1093/oncolo/oyab006

N/A

0.470DataRank · unranked

22 citations

Van K. Morris, Benny Johnson, Cathy Eng, Ethan B. Ludmir, Prajnan Das +15 more

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162

N/A

0.464DataRank · unranked

21 citations

Jane E. Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind Dasari +11 more

Clinical and pathologic features correlated with rare favorable survival in patients with BRAFV600E mutated colorectal cancer

Journal of Gastrointestinal Oncology(2022)10.21037/jgo-21-471

N/A

0.241DataRank · unranked

4 citations

Bryan K. Kee, Michael J. Overman, Arvind Dasari, Kanwal Raghav, Benny Johnson +6 more

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3520

N/A

0DataRank · unranked

9 citations

Eduardo Vilar Sanchez, Ryan Sun, Madhulika Eluri, Van K. Morris, Benny Johnson +11 more

Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors

medRxiv(2022)10.1101/2022.02.17.22271120

N/A

0DataRank · unranked

1 citations

Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A. Nebhan, Ibiayi Dagogo‐Jack +24 more

RAS co-mutation and early onset disease represent an aggressive phenotype of atypical (non-V600) BRAF mutant metastatic colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3592

N/A

0DataRank · unranked

0 citations

Dongyun Yang, Hiba I. Dada, Van K. Morris, Xuemei Wang, Arvind Dasari +14 more

Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0340

N/A

0DataRank · unranked

15 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers

The Oncologist(2023)10.1093/oncolo/oyad085

N/A

0DataRank · unranked

28 citations

Amir A. Jazaeri, Shannon N. Westin, Curtis A. Pettaway, Solly George, Ryan Huey +8 more

Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer

Cancers(2023)10.3390/cancers15061701

N/A

0DataRank · unranked

7 citations

Prajnan Das, Emma B. Holliday, Li Shen, Wei Lü, Benny Johnson +20 more

Data from Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

(2023)10.1158/0008-5472.c.6513959.v1

N/A

0DataRank · unranked

0 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

Supplementary Figure from Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

(2023)10.1158/0008-5472.22431731

N/A

0DataRank · unranked

0 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

Data from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

(2023)10.1158/2767-9764.c.6550830.v1

N/A

0DataRank · unranked

0 citations

Michael J. Overman, Michael Hon‐Wah Lam, Christine M. Parseghian, Benny Johnson, Arvind Dasari +17 more

Is there an increase in elective utilization of non-operative management for rectal cancer?

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15533

N/A

0DataRank · unranked

0 citations

Chung‐Yuan Hu, Abhineet Uppal, Oliver Peacock, Brian K. Bednarski, Tsuyoshi Konishi +13 more

Data from Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

(2023)10.1158/2767-9764.c.6975005.v1

Top 100%

0DataRank

Top 100%0 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Population-based Screening for BRAF V600E in Metastatic Colorectal Cancer Reveals Increased Prevalence and Poor Prognosis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1024

N/A

0DataRank · unranked

43 citations

Benny Johnson, Laveniya Kugathasan, Van K. Morris, Kanwal Raghav, Lucas Swanson +9 more

Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer: impact of treatment modalities and resection status

Colorectal Disease(2025)10.1111/codi.70110

N/A

0DataRank · unranked

3 citations

Oliver Peacock, Brian K. Bednarski, Arvind Dasari, Prajnan Das, Benny Johnson +5 more

Integration of Whole-Genome Sequencing With Circulating Tumor DNA Analysis Captures Clonal Evolution and Tumor Heterogeneity in Non-V600 BRAF Mutant Colorectal Cancer

Clinical Colorectal Cancer(2020)10.1016/j.clcc.2020.02.001

N/A

0DataRank · unranked

2 citations

Miguel Alcaide, James T. Topham, Benny Johnson, Ryan D. Morin, Jenny E. Chu +11 more

Phase II trial of bintrafusp alfa in patients with metastatic MSI-H cancers following progression on immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.79

N/A

0DataRank · unranked

15 citations

Michael Lam, Xuemei Wang, Michael J. Overman, Benny Johnson, Bryan K. Kee +7 more

Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

Cancer Research(2022)10.1158/0008-5472.can-22-0198

N/A

0DataRank · unranked

81 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

Benny Johnson

Indexed papers

Top data-sharing exemplar

Papers